Related Experiment Videos
[Viral hepatitis: Croatian consensus statement].
Boris Vucelić1, Irena Hrstić, Josip Begovac
1Zavod za gastroenterologiju, Klinika za unutrasnje bolesti, Klinicki bolnicki centar Zagreb, Kispatićeva 12, 10000 Zagreb, Hrvatska. boris.vucelic@zg.htnet.hr
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
|December 31, 2005
Summary
Advances in viral hepatitis diagnosis and therapy offer long-term cost savings despite initial treatment increases. Croatian experts convened to establish national guidelines for viral hepatitis management.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health Policy
Context:
- Viral hepatitis diagnosis and treatment have significantly advanced over the past two decades.
- Therapeutic improvements, while increasing upfront costs, lead to long-term savings by reducing the need for advanced liver disease interventions.
- Liver transplantation costs are a key consideration in the economic impact of viral hepatitis management.
Purpose:
- To develop national consensus recommendations for viral hepatitis diagnosis, prophylaxis, and therapy tailored to Croatian circumstances.
- To consolidate expert opinion and provide evidence-based guidance for healthcare professionals in Croatia.
- To address the evolving landscape of viral hepatitis management and its associated costs.
Summary:
- A consensus conference was held in Zagreb in June 2004, with an update in March 2005, involving leading Croatian experts in viral hepatitis.
- The conference was organized by the Croatian National Board for Viral Hepatitis and several other key medical societies and governmental bodies.
- Participants provided written reports and formulated consensus statements based on the latest advancements in the field.
Impact:
- The consensus statement provides crucial recommendations for optimizing viral hepatitis care in Croatia.
- It aims to guide clinical practice, improve patient outcomes, and manage healthcare costs effectively.
- This initiative sets a precedent for evidence-based policy-making in infectious disease management within the country.